ProfileGDS4718 / 228400_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 97% 98% 87% 98% 98% 89% 89% 97% 98% 98% 97% 97% 96% 93% 93% 96% 97% 88% 92% 75% 97% 98% 97% 97% 97% 94% 97% 83% 97% 94% 96% 91% 97% 97% 91% 91% 93% 96% 97% 77% 98% 90% 91% 83% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]11.284397
GSM549102patient 115, normal, homogenized [OPG study]11.435798
GSM549104patient 119, normal, homogenized [OPG study]8.7436887
GSM549108patient 138, normal, homogenized [OPG study]11.188298
GSM549119patient 077, normal, homogenized [OPG study]11.5298
GSM549133patient 032, cancer, homogenized [OPG study]9.093389
GSM549139patient 042, cancer, homogenized [OPG study]9.0190189
GSM549099patient 107, normal, homogenized [OPG study]10.909997
GSM549109patient 139, normal, homogenized [OPG study]11.43198
GSM549110patient 046, normal, homogenized [OPG study]11.430298
GSM549114patient 063, normal, homogenized [OPG study]11.274797
GSM549122patient 082, normal, homogenized [OPG study]10.981397
GSM549134patient 033, cancer, homogenized [OPG study]10.36996
GSM549136patient 036, cancer, homogenized [OPG study]9.7811593
GSM549140patient 044, cancer, homogenized [OPG study]9.7242593
GSM549111patient 047, normal, homogenized [OPG study]10.619896
GSM549113patient 057, normal, homogenized [OPG study]11.204897
GSM549132patient 031, cancer, homogenized [OPG study]8.8418888
GSM549137patient 038, cancer, homogenized [OPG study]9.4315692
GSM549142patient 047, cancer, homogenized [OPG study]7.2087775
GSM549100patient 110, normal, homogenized [OPG study]10.782797
GSM549107patient 135, normal, homogenized [OPG study]11.369498
GSM549115patient 068, normal, homogenized [OPG study]11.15597
GSM549116patient 072, normal, homogenized [OPG study]11.04597
GSM549120patient 078, normal, homogenized [OPG study]11.169697
GSM549131patient 030, cancer, homogenized [OPG study]9.9865394
GSM549118patient 074, normal, homogenized [OPG study]11.109497
GSM549129patient 027, cancer, homogenized [OPG study]8.1693183
GSM549123patient 088, normal, homogenized [OPG study]11.246697
GSM549124patient 006, cancer, homogenized [OPG study]9.8932494
GSM549126patient 015, cancer, homogenized [OPG study]10.47896
GSM549128patient 025, cancer, homogenized [OPG study]9.3992191
GSM549103patient 117, normal, homogenized [OPG study]11.141597
GSM549117patient 073, normal, homogenized [OPG study]11.297
GSM549138patient 041, cancer, homogenized [OPG study]9.284591
GSM549141patient 045, cancer, homogenized [OPG study]9.3848891
GSM549130patient 028, cancer, homogenized [OPG study]9.6254793
GSM549101patient 111, normal, homogenized [OPG study]10.478796
GSM549105patient 128, normal, homogenized [OPG study]11.05697
GSM549106patient 134, normal, homogenized [OPG study]7.7144677
GSM549112patient 048, normal, homogenized [OPG study]11.331598
GSM549125patient 011, cancer, homogenized [OPG study]9.202190
GSM549127patient 024, cancer, homogenized [OPG study]9.2355991
GSM549135patient 035, cancer, homogenized [OPG study]8.3394183